<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04632823</url>
  </required_header>
  <id_info>
    <org_study_id>AstanaMU-1</org_study_id>
    <nct_id>NCT04632823</nct_id>
  </id_info>
  <brief_title>&quot;The Effect of Comprehensive Non-pharmacological Treatment on Metabolic Disorders in Type 2 Diabetic Patients&quot;</brief_title>
  <official_title>&quot;The Effect of Comprehensive Non-pharmacological Treatment on Metabolic Disorders in Type 2 Diabetic Patients&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Astana Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Astana Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of the effectiveness of comprehensive non-pharmacological treatment on metabolic&#xD;
      disorders in type 2 diabetic patients&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients in the intervention group will participate in a comprehensive non-pharmacological&#xD;
      treatment of type 2 diabetes, the main components are:&#xD;
&#xD;
        -  changing the meal plan (individual and group counseling, assistance in developing menus&#xD;
           and determining the calorie intake, keeping a food diary)&#xD;
&#xD;
        -  individually dosed physical exercises using specific exercise program;&#xD;
&#xD;
        -  comprehensive training (course of interactive lessons, self-control training). The&#xD;
           program included group sessions with a team of specialists: nutritionist,&#xD;
           endocrinologist, physical therapy doctor and included 3 sessions per week for 24 weeks.&#xD;
           Each visit included teaching patients in a group format and in an interactive form&#xD;
           (classes with specialists alternated), performing physical exercises using the specific&#xD;
           exercise program under the supervision of a physiotherapy physician, evaluating medical&#xD;
           indicators, and a self-control diary.&#xD;
&#xD;
      Patients in the control group will not participate in group sessions, but they had the&#xD;
      opportunity to receive non-pharmacological care provided in the framework of free outpatient&#xD;
      care. Their indicators will be recorded during a routine visit to the doctor at the baseline,&#xD;
      after 12 and 24 weeks.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Anticipated">June 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>prospective, single-center</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline Glycosylated Hemoglobin at 6 months</measure>
    <time_frame>at baseline and at 24-week postrandomization</time_frame>
    <description>HbA1c value</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline Body Mass Index at 6 months</measure>
    <time_frame>at baseline and at 24-week postrandomization</time_frame>
    <description>BMI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Blood Pressure at 6 months</measure>
    <time_frame>at baseline and at 24-week postrandomization</time_frame>
    <description>Systolic and diastolic blood pressure at the brachial artery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Lipid Profiles at 6 months</measure>
    <time_frame>at baseline and at 24-week postrandomization</time_frame>
    <description>Total Triglyceride, Total Cholesterol, high-density lipoprotein (HDL), and low-density lipoprotein (LDL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Homeostasis ModelAssessment of Insulin Resistance at 6 months (HOMA-IR)</measure>
    <time_frame>at baseline and at 24-week postrandomization</time_frame>
    <description>Homeostasis ModelAssessment of Insulin Resistance</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>Comprehensive non-pharmacological program intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The experimental group receives usual diabetes care plus 24 weeks of the comprehensive non-pharmacological program intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual diabetes care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This group is control, the patients receive usual diabetes care routines.</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Comprehensive Non-pharmacological Treatment Program</intervention_name>
    <description>dietary supplement, specific type of exercise, self-management education</description>
    <arm_group_label>Comprehensive non-pharmacological program intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  medically diagnosed with type 2 diabetes mellitus&#xD;
&#xD;
          -  HbA1c result of ≤7.0% within the past 2 months&#xD;
&#xD;
          -  body mass index (BMI) of ≥26 kg/m^2&#xD;
&#xD;
          -  hypoglycemic therapy: metformin only&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  the use of other hypoglycemic drugs&#xD;
&#xD;
          -  the use of medication for weight loss&#xD;
&#xD;
          -  cardiovascular diseases (heart attack or cardiac procedure within the past 3 months)&#xD;
&#xD;
          -  had stroke or history of treatment for transient ischemic attacks in the past 3 months&#xD;
&#xD;
          -  had chronic renal failure or were on dialysis&#xD;
&#xD;
          -  any conditions that do not allow the patient to perform the complex of the proposed&#xD;
             physical exercises&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>59 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Viktoriya Li, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Astana Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Viktoriya Li, PhD</last_name>
    <phone>+77785568055</phone>
    <email>liviktoriya0509@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>West Kazakhstan Marat Ospanov Medical University</name>
      <address>
        <city>Aktobe</city>
        <state>Aktobe Region</state>
        <zip>030000</zip>
        <country>Kazakhstan</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Astana Medical University</name>
      <address>
        <city>Astana</city>
        <zip>010000</zip>
        <country>Kazakhstan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yerbolat Dalenov, Professor</last_name>
      <phone>+77017694241</phone>
      <email>dalenov.e@amu.kz</email>
    </contact>
    <investigator>
      <last_name>Anna Bazarova, Docent</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Center for Preventive Medicine and Life Extension of Nur-Sultan</name>
      <address>
        <city>Astana</city>
        <zip>010000</zip>
        <country>Kazakhstan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Viktoriya Li, PhD</last_name>
      <phone>+77785568055</phone>
      <email>liviktoriya0509@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Medical Research Center for Endocrinology, Ministry of Health of the Russian Federation</name>
      <address>
        <city>Moscow</city>
        <zip>101000</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Kazakhstan</country>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 9, 2020</study_first_submitted>
  <study_first_submitted_qc>November 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2020</study_first_posted>
  <last_update_submitted>November 16, 2020</last_update_submitted>
  <last_update_submitted_qc>November 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Astana Medical University</investigator_affiliation>
    <investigator_full_name>Viktoriya Li</investigator_full_name>
    <investigator_title>PhD, Head of Rehabilitation</investigator_title>
  </responsible_party>
  <keyword>type 2 diabetes mellitus</keyword>
  <keyword>non-pharmacological treatment</keyword>
  <keyword>lifestyle intervention</keyword>
  <keyword>structured program</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Metabolic Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

